Getinge Acquires High Purity New England

Getinge AB has agreed to acquire 100% of High Purity New England (HPNE), a U.S.-based provider of custom single-use solutions for bioprocessing, for approximately SEK 1,300 million (USD 120 million) in cash plus a potential earn-out. The acquisition strengthens Getinge Life Science’s biopharma capabilities and expands its single-use product offering; HPNE is headquartered in Smithfield, Rhode Island and has roughly 150 employees.